Tyvaso 64 MCG kit
Ended Awarded Last action
- Contract number
- 36C24526N0374
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,352
Award facts
- Contract value 100% obligated
- $17,351.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $17,351.60 to United Therapeutics Corp for the supply of Tyvaso 64 microgram kits. The contract, issued under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), is structured as a firm fixed-price delivery order with no set-aside designation. The ultimate completion date is March 11, 2026, with the order placed on March 3, 2026. Performance of this contract is located in Bartlett, Tennessee.
This delivery order is executed under a larger single-award Blanket Purchase Agreement between the Department of Veterans Affairs National Acquisition Center and United Therapeutics Corp, valued at $207.1 million with a ceiling date of April 23, 2026. The BPA covers four critical pharmaceutical products—Unituxin, Remodulin, Tyvaso, and Orenitram—which are essential treatments for pulmonary arterial hypertension and select oncology conditions affecting the veteran population. United Therapeutics Corp, a biotechnology manufacturer headquartered in Silver Spring, Maryland, specializes in developing treatments for rare and life-threatening medical conditions and serves as a significant supplier of specialized pharmaceuticals to the VA across multiple VISNs nationwide.
Quick answers
Who was awarded contract 36C24526N0374?
36C24526N0374 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 3, 2026.
How much is contract 36C24526N0374 worth?
The government has obligated $17,352 on 36C24526N0374.
Is contract 36C24526N0374 an order under another contract?
Yes. 36C24526N0374 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0374 competed?
The extent of competition for 36C24526N0374 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award